Medicine News and Research

RSS

Study shows that laser surgery lawsuits against non-physicians on the rise

A new study showing increasing numbers of lawsuits being filed against non-physicians performing laser surgery has important implications for patient safety, according to the American Society for Dermatologic Surgery Association.

17 Oct 2013

CardioFocus completes HeartLight EAS pivotal trial enrollment for symptomatic paroxysmal AF

CardioFocus, Inc., developer of the HeartLight Endoscopic Ablation System for the treatment of atrial fibrillation, today announced that it has concluded enrollment of its U.S. pivotal trial evaluating the HeartLight system, for the treatment of symptomatic paroxysmal AF.

17 Oct 2013

Liverpool Care Pathway provides little clinical benefit for dying cancer patients

The first randomised trial to test the effectiveness of the Liverpool Care Pathway (LCP) programme, developed and implemented widely to support patients as they near death, has found little clinical benefit compared with standard care for cancer patients dying in hospital.

17 Oct 2013

Air pollution hampers fetal growth

Exposure to common air pollutants and traffic during pregnancy significantly increases the risk of restricted fetal growth, even at levels well below those stipulated in current European Union (EU) air-quality directives, according to one of the largest studies of its kind, published in The Lancet Respiratory Medicine.

17 Oct 2013

Scientists identify recessive gene mutation that reduces certain protein affecting brain development

Though worlds apart, four unrelated families have been united in a medical mystery over the source of a rare inherited disorder that results in their children being born with abnormal brain growth and severe functional impairments.

17 Oct 2013

Thyroid specialists recommend thyroid function testing for pregnant women

Decreased thyroid function can have a detrimental effect on pregnancy outcomes. A majority of thyroid specialists surveyed recommend thyroid function testing for all pregnant women. The results of a survey conducted at the 2012 annual meeting of the American Thyroid Association will be delivered in a poster to be presented at the upcoming 83rd Annual Meeting of the ATA, October 16-20, 2013, in San Juan, Puerto Rico.

17 Oct 2013

Doctors who make eye contact seem more empathetic to patients

Doctors who make a lot of eye contact are viewed as more likable and empathetic by patients, according to a new Northwestern Medicine- study.

17 Oct 2013

Researchers use technology to help immobilized stroke survivors regain some independence

A team of researchers from Montreal has found that stroke patients living with Locked-In Syndrome (LIS) who cannot move, swallow or even breathe on their own, can regain a remarkable level of independence with technological help.

17 Oct 2013

Use of antibiotics to treat catheter-associated bacteriuria infection show no change in mortality rates

With 30 million indwelling bladder catheters placed annually nationwide, patients face an increased risk of developing catheter-associated bacteriuria (bacteria in the urine). Many patients with indwelling urinary catheters acquire bacteria in the urinary tract while they are catheterized.

17 Oct 2013

Study focuses on vaccine-preventable illnesses in myasthenia gravis patients

A study presented at the annual meeting of the American Association of Neuromuscular & Electrodiagnostic Medicine is considered a good first step in collecting data on vaccine-preventable illnesses in patients with myasthenia gravis, a neuromuscular disorder causing weakness and rapid fatigue of voluntary muscles.

17 Oct 2013

Using mobile device to check drug info prevents adverse events, say nursing home doctors

Nearly nine out of 10 nursing home physicians said that using their mobile devices to look up prescription drug information prevented at least one adverse drug event in the previous month, according to a University of Pittsburgh School of Medicine Department of Biomedical Informatics study published last week in the Journal of the American Medical Directors Association.

17 Oct 2013

Nintedanib drug to treat NSCLC is submitted for approval from European Medicines Agency

Boehringer Ingelheim announced the submission of a Marketing Authorisation Application to the European Medicines Agency for the approval of its oral triple angiokinase inhibitor nintedanib, in combination with docetaxel, for the treatment of patients with locally advanced, metastatic or recurrent non-small cell lung cancer (NSCLC) of adenocarcinoma tumour histology after first line chemotherapy.

17 Oct 2013

Cambridge professor to speak about nature of viruses at free public lecture at University of Leicester

Former Regius Professor of Physic at the University of Cambridge to deliver public lecture on Monday 21 October

17 Oct 2013

BRAF inhibitor vemurafenib effective for patients with papillary thyroid cancer

Mutations in a gene that codes for the enzyme BRAF kinase have been associated with increased risk for papillary thyroid cancer. An early-stage clinical trial of the BRAF inhibitor vemurafenib resulted in either a partial response or stable disease in patients with PTC and BRAF mutations.

17 Oct 2013

Study explores advantages of minimally invasive parathyroidectomy for treating hyperparathyroidism

An open surgical procedure called bilateral neck exploration has been the gold standard operation for treating patients with primary hyperparathyroidism. But the development of a minimally invasive procedure to remove the parathyroid gland now offers a new option.

17 Oct 2013

Cedars-Sinai awards $3.3M grants to organizations dedicated to community health, education and safety

Cedars-Sinai is awarding $3.3 million in grants to organizations dedicated to community health, education and safety for projects that will benefit residents in neighborhoods throughout Los Angeles, including South Los Angeles, West Hollywood and Venice.

17 Oct 2013

Researchers find novel drug target for anaplastic thyroid carcinomas

Anaplastic thyroid carcinomas are aggressive tumors that do not respond to traditional radio- or chemotherapeutic agents, and there currently is no cure or effective treatment available. Median survival from diagnosis is 5 months, and although ATC accounts for only 1.7% of all thyroid cancers in the U.S., it is responsible for a large proportion of thyroid cancer-related deaths.

17 Oct 2013

Scientists identify 127 mutated genes that appear to drive development of tumors in the body

Examining 12 major types of cancer, scientists at Washington University School of Medicine in St. Louis have identified 127 repeatedly mutated genes that appear to drive the development and progression of a range of tumors in the body. The discovery sets the stage for devising new diagnostic tools and more personalized cancer treatments.

17 Oct 2013

Research findings point the way to new class of antibiotics for skin and heart infections

Researchers at NYU Langone Medical Center have discovered a new mechanism by which the deadly Staphylococcus aureus bacteria attack and kill off immune cells. Their findings, published today in the journal Cell Host & Microbe, explain a critical survival tactic of a pathogen that causes more skin and heart infections than any other microbe, and kills more than 100,000 Americans every year.

17 Oct 2013

New England publishes results of phase III clinical trial of ABRAXANE for metastatic pancreatic cancer

Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation , today announced the results of the MPACT phase III clinical trial of ABRAXANE® in combination with gemcitabine were published online in the October 16th edition of the New England Journal of Medicine.

17 Oct 2013

Medicine News and Research

Study shows that laser surgery lawsuits against non-physicians on the rise

CardioFocus completes HeartLight EAS pivotal trial enrollment for symptomatic paroxysmal AF

Liverpool Care Pathway provides little clinical benefit for dying cancer patients

Air pollution hampers fetal growth

Scientists identify recessive gene mutation that reduces certain protein affecting brain development

Thyroid specialists recommend thyroid function testing for pregnant women

Doctors who make eye contact seem more empathetic to patients

Researchers use technology to help immobilized stroke survivors regain some independence

Use of antibiotics to treat catheter-associated bacteriuria infection show no change in mortality rates

Study focuses on vaccine-preventable illnesses in myasthenia gravis patients

Using mobile device to check drug info prevents adverse events, say nursing home doctors

Nintedanib drug to treat NSCLC is submitted for approval from European Medicines Agency

Cambridge professor to speak about nature of viruses at free public lecture at University of Leicester

BRAF inhibitor vemurafenib effective for patients with papillary thyroid cancer

Study explores advantages of minimally invasive parathyroidectomy for treating hyperparathyroidism

Cedars-Sinai awards $3.3M grants to organizations dedicated to community health, education and safety

Researchers find novel drug target for anaplastic thyroid carcinomas

Scientists identify 127 mutated genes that appear to drive development of tumors in the body

Research findings point the way to new class of antibiotics for skin and heart infections

New England publishes results of phase III clinical trial of ABRAXANE for metastatic pancreatic cancer

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News